Efficacy and safety of a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer alone and in combination with immune checkpoint inhibitors

被引：1
|
作者：
Williams, William [1 ]
Dakhil, Shaker R. [2 ]
Holmes, Jarrod P. [3 ]
Bhattacharya, Saveri [4 ]
Calfa, Carmen [5 ]
Kundra, Ajay [6 ]
Adams, Daniel L. [7 ]
DaSilva, Diane [8 ]
Peoples, George E. [9 ]
Sunkari, Vivek [1 ]
Lacher, Markus [1 ]
Wiseman, Charles L. [1 ]
机构：
[1] BriaCell Therapeut Corp, Berkeley, CA USA
[2] Canc Ctr Kansas, Wichita, KS USA
[3] Redwood Reg Med Grp, Santa Rosa, CA USA
[4] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[5] Univ Miami, Miami, FL USA
[6] Everett Clin, Everett, WA USA
[7] Creatv MicroTech, Rockville, MD USA
[8] Univ Southern Calif, Los Angeles, CA 90007 USA
[9] Canc Insight LLC, San Antonio, TX USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P3-09-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-09-08
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Initial safety and efficacy of a phase I/IIa trial of a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer
    Bhattacharya, S.
    Holmes, J. P.
    Calfa, C.
    Lukas, J.
    Tan-Chiu, E.
    Clifton, G. T.
    Peoples, G. E.
    Lacher, M.
    Wiseman, C. L.
    Williams, W. V.
    CANCER RESEARCH, 2019, 79 (04)
  • [2] Breast cancer grade and clinical benefit in patients with advanced breast cancer treated with an engineered whole tumor cell-targeted immunotherapy alone or in combination with checkpoint inhibition.
    Williams, William
    Dakhil, Shaker R.
    Calfa, Carmen Julia
    Holmes, Jarrod P.
    Bhattacharya, Saveri
    Lukas, Jason Jerome
    Tan-Chiu, Elizabeth
    Peoples, George Earl
    Sunkari, Vivekananda
    Lacher, Markus
    Wiseman, Charles L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Response to a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer correlates with tumor grade
    Williams, William
    Dakhil, Shaker R.
    Calfa, Carmen
    Holmes, Jarrod P.
    Bhattacharya, Saveri
    Lukas, Jason
    Tan-Chiu, Elizabeth
    Peoples, George E.
    Sunkari, Vivek G.
    Lacher, Markus D.
    Wiseman, Charles L.
    CANCER RESEARCH, 2021, 81 (04)
  • [4] Safety and efficacy of a phase I/IIa trial (NCT03066947) of a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer.
    Williams, William
    Holmes, Jarrod P.
    Bhattacharya, Saveri
    Calfa, Carmen
    Dakhil, Shaker R.
    Lukas, Jason Jerome
    Tan-Chiu, Elizabeth
    Adams, Daniel
    Peoples, George
    Lacher, Markus
    Wiseman, Charles L.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Overall survival following treatment with a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer
    Williams, William
    Dakhil, Shaker R.
    Calfa, Carmen
    Holmes, Jarrod P.
    Bhattacharya, Saveri
    Lukas, Jason
    Tan-Chui, Elizabeth
    Peoples, George E.
    Sunkari, Vivek G.
    Lacher, Markus D.
    Wiseman, Charles L.
    CANCER RESEARCH, 2022, 82 (04)
  • [6] Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment
    Zhao, Jing
    Chen, Ye
    Ding, Zhen-Yu
    Liu, Ji-Yan
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [7] Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy
    Marquez-Garban, Diana C.
    Deng, Gang
    Comin-Anduix, Begonya
    Garcia, Alejandro J.
    Xing, Yanpeng
    Chen, Hsiao-Wang
    Cheung-Lau, Gardenia
    Hamilton, Nalo
    Jung, Michael E.
    Pietras, Richard J.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2019, 193
  • [8] Combination of photosensitizer and immune checkpoint inhibitors for improving the efficacy of tumor immunotherapy
    Li, Kexin
    Yu, Huan
    Bao, Zhihong
    Xu, Lu
    Zhang, Hong
    Wang, Tian
    Yu, Longyue
    Yuan, Yue
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 629
  • [9] Efficacy of combination of immune checkpoint inhibitors, chemotherapy, and targeted therapy in advanced/refractory cancer.
    Salem, Philip A.
    Gensini, Lorenzo
    McCallum, William G. B.
    Hanna, John
    Wheeler, Thomas M.
    Stenoien, Randall A.
    Jabboury, Khaled W.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 41 - 41
  • [10] Safety and efficacy of a whole-cell targeted immunotherapy for breast cancer: Preliminary findings
    Holmes, Jarrod P.
    Tan-Chiu, Elizabeth
    Wiseman, Charles L.
    Lacher, Markus D.
    Peoples, George
    Williams, William V.
    CANCER RESEARCH, 2018, 78 (13)
12345